Skip to main content

Table 3 Self-reported symptom distribution before treatment, as noted in the patient’s medical records (n = 263)

From: Evaluation of treatment with two weeks of doxycycline on macrolide-resistant strains of Mycoplasma genitalium: a retrospective observational study

 

Female

Male

Total

Asymptomatic

91 (55.2%)

51 (52.0%)

142 (54.0%)

Symptoms present

67 (40.6%)

41 (41.8%)

108 (41.1%)

Dysuria

19 (11.5%)

32 (32.7%)

51 (19.4%)

Frequent urination

4 (2.4%)

1 (1.0%)

5 (1.9%)

Discharge*

38 (23.0%)

19 (19.4%)

57 (21.7%)

Itching

11 (6.7%)

9 (9.2%)

20 (7.6%)

Abdominal or pelvic pain/discomfort

6 (3.6%)

0

6 (2.3%)

Vaginal bleeding**

9 (5.5%)

NA

9 (3.4%)

Throat discomfort

2 (1.2%)

0

2 (0.8%)

Not stated

7 (4.2%)

6 (6.1%)

13 (4.9%)

  1. *Discharge includes any change in discharge such as increased amount, odor, color and consistency
  2. **Vaginal bleeding includes any abnormal bleeding, such as post-coital bleeding, bleeding between periods and bloody discharge